Fate Therapeutics Inc (FATE)

3.99
0.05 1.30
NASDAQ : Health Care
Prev Close 3.94
Open 3.94
Day Low/High 3.89 / 4.05
52 Wk Low/High 1.46 / 8.05
Volume 54.26K
Avg Volume 235.40K
Exchange NASDAQ
Shares Outstanding 41.42M
Market Cap 171.05M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

More Immunotherapy Buyouts Likely After Kite Sale

Fate Therapeutics Announces Issuance Of U.S. Patent Covering Use Of Viral Transduction Enhancers In Gene Therapy

Fate Therapeutics Announces Issuance Of U.S. Patent Covering Use Of Viral Transduction Enhancers In Gene Therapy

Patent Broadly Protects the Use of Prostaglandins for Enhancing Gene Transfer in Blood Stem Cells

Biotech Movers: Fate Shares Spike After Cancer Studies Progress

Biotech Movers: Fate Shares Spike After Cancer Studies Progress

Fate's first subject has been treated with FATE-NK100 for AML and two additional clinical trials of FATE-NK100 for the treatment of multiple advanced solid tumor types will soon open.

Fate Therapeutics To Kick-Off 2017 Annual Meeting Of International Society For Stem Cell Research With Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Focus Session

New Preclinical Data to be Presented on First-of-Kind Product Candidates Derived from Master Engineered Pluripotent Cell Lines

The Setup Is Good for a Bounce, but it Hasn't Happened Yet

The Setup Is Good for a Bounce, but it Hasn't Happened Yet

Some small names are interesting, but more-aggressive position trades are not developing right now.

3 Small Biotechs With Insider Buying

3 Small Biotechs With Insider Buying

Insiders have an edge in this complex sector, so it's worth checking them out.

On the Hunt for Holiday Movers

On the Hunt for Holiday Movers

I'm still bullish, but I'm looking over my shoulder to see if there are some bears sneaking up.

Rotation Is the Name of the Game

Rotation Is the Name of the Game

Traders are also looking for smaller-caps that can move big around the holiday.

Shark Bites: These Steel Names Are Looking Strong

Shark Bites: These Steel Names Are Looking Strong

A few plays on this holiday trading.

TheStreet Quant Rating: D (Sell)